Thrivent Financial for Lutherans Sells 1,040 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Thrivent Financial for Lutherans reduced its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 5.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 17,366 shares of the medical instruments supplier’s stock after selling 1,040 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Mettler-Toledo International were worth $21,251,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Axxcess Wealth Management LLC grew its position in shares of Mettler-Toledo International by 6.7% in the 4th quarter. Axxcess Wealth Management LLC now owns 870 shares of the medical instruments supplier’s stock worth $1,065,000 after buying an additional 55 shares during the last quarter. Cibc World Markets Corp grew its position in shares of Mettler-Toledo International by 13.0% in the 4th quarter. Cibc World Markets Corp now owns 3,315 shares of the medical instruments supplier’s stock worth $4,056,000 after buying an additional 382 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Mettler-Toledo International by 5.8% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 513 shares of the medical instruments supplier’s stock valued at $628,000 after purchasing an additional 28 shares during the period. Frank Rimerman Advisors LLC lifted its stake in shares of Mettler-Toledo International by 7.4% in the 4th quarter. Frank Rimerman Advisors LLC now owns 408 shares of the medical instruments supplier’s stock valued at $499,000 after purchasing an additional 28 shares during the period. Finally, Intact Investment Management Inc. purchased a new position in shares of Mettler-Toledo International in the 4th quarter valued at approximately $122,000. 95.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on MTD. Citigroup lowered their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Wells Fargo & Company raised their target price on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Evercore ISI raised their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Robert W. Baird raised their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Finally, Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $1,380.50.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Down 1.6 %

Shares of NYSE:MTD opened at $1,200.33 on Friday. The stock has a fifty day simple moving average of $1,293.03 and a two-hundred day simple moving average of $1,312.51. The stock has a market capitalization of $25.11 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12-month low of $1,142.91 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, equities research analysts predict that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.